TMCnet News
Stocks That Stand Out For Nov. 17th, 2009 Are GCHT, CBIS, BRYN, XCEL(M2 PressWIRE Via Acquire Media NewsEdge) www.Standoutstocks.com: Stocks That Standout For Nov. 17th, 2009 are GC China Turbine Corp. (OTCBB: GCHT), Cannabis Science Inc. (OTCBB: CBIS), BRYN Resources Inc (PINKSHEETS: BRYN), Xcellink International Inc. (OTCBB: XCEL) Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com _________________________________________________ GC China Turbine Corp. Signs MOU to Develop Major Coastal Wind Power Project in China NEW YORK, NY, Nov 17, 2009 -- GC China Turbine Corp. (OTCBB: GCHT) (the "Company" or "GC China") a manufacturer of state-of-the art 2 blade wind turbines is pleased to announce that it has recently entered into a Memorandum of Understanding ("MOU") with the Yancheng regional government of Jiangsu province with the intent to develop a local manufacturing base from which to build large utility scale turbines for offshore and coastal use in the area. Preliminary plans call for the development of several local offshore wind farms, each offering 500 megawatt (MW) capacity. Initial estimates by the Company place the value of potential orders for a project of this scale at approximately $US 732 million. GC China aims to work in conjunction with regional vendors and has further identified localized industry suppliers that would ultimately benefit the venture as either merger or acquisition opportunities. The Company plans to further increase the momentum at its Swedish joint venture R&D facility towards final stage development of the new 3.0 MW turbine as the prime offering best suited to exploit the extraordinary wind conditions of the region. Current plans in Jiangsu aim to initiate a 2010 campaign of regional target acquisitions, upgrades at key local facilities and commencement of trial production and manufacturing of the new turbines. In a move similar to many European countries, China has attached increasing importance to the development of its offshore wind assets. Compared to inland wind energy markets, the wind resource reserves are significantly more abundant in coastal areas. Research shows that the potential wind energy reserve in inland areas is 250 gigawatts, versus 750 gigawatts along coastal areas. Among the government mandated programs announced to-date, which include seven projects encompassing 10 gigawatts of wind energy, the coastal area in Jiangsu Province is the primary location and key to construction planning of what many are now referring to as the "Marine Three Gorges Project" as a favorably comparative reference to the largest traditional hydroelectric project constructed in China so far. GC China Turbine Corp. views this opportunity as an extraordinary step in the long term growth of the Company and fully intends to maximize any investment via its proven management ability applied towards the development of a world-class manufacturing base and support infrastructure around what is rapidly becoming the hottest spot in the nation for the future of wind power in China. Further details regarding the Company and its agreements along with further information about the business, financial condition and management of GC China and related parties are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. About GC China Turbine Corp. (OTCBB: GCHT) GC China is a leading manufacturer of state-of-the-art 2-bladed wind turbines based in Wuhan City of Hubei Province, China. The Company holds a license to manufacture a groundbreaking technology which meets rigorous requirements for low-cost and high reliability. The technology was developed through a 10 year European research project costing over US$ 75 million. GC China's launch product is a 1.0 megawatt ("MW") utility scale turbine with designs for a 2.3MW and 3.0MW utility scale turbine in development. The Company's initial efforts have been rewarded with contracts of approximately US$ 128 million to-date. Notice Regarding Forward-Looking Statements This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines... COLORADO SPRINGS, Colo., Nov 16, 2009 -- Cannabis Science Hails The American Medical Association For Urging The United States To Facilitate Clinical Research and Development of Cannabinoid-Based Medicines Which Validates The Company's Strategy To Produce Critically Important FDA Approved Cannabinoid-Based Medicines For Patients Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is hailing the call by the American Medical Association's House of Delegates for "marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines." Richard Cowan, Cannabis Science CFO, noted, "The AMA has officially joined the other medical groups in their recognition of the medical value of cannabis. Last year, the American College of Physicians also called for a reclassification of cannabis' Schedule I status. Previously, many other health organizations, including the American Nurses Association and the American Public Health Association, have called for the legal recognition of medical cannabis." Under federal law, all substances in Schedule I are defined as possessing "no currently accepted use in treatment in the United States" and also having a high potential for abuse. In 1970 Congress classified marijuana, and all of the cannabinoids (even those with no psychoactive properties) as Schedule I substances upon passage of the Controlled Substances Act. This classification was supposed to be temporary, but blocking research kept it in Schedule I. Dr. Robert Melamede, PhD., Cannabis Science Inc. President and CEO, stated, "It is now clear that the AMA has embraced the plethora of peer reviewed science supporting the medical applications of the cannabis plant. Their call for the US to facilitate 'research and development of cannabinoid-based medicines' is an important validation of our company's strategy and should make it much easier for us to develop and market products that will help patients. Most people would be shocked to know that the federal government has actually been blocking research on the medical benefits of cannabis while supporting research aimed at demonstrating the negatives. Now that the AMA has embraced this modern science, and President Obama has created new Federal policies and guidelines, the Federal Government can no longer ignore the importance of cannabinoid-based medicines." About Cannabis Science, Inc. Cannabis Science, Inc. is at the forefront of medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements. Bryn Resources Inc. Provides Corporate Update TORONTO, Nov 17, 2009 -- BRYN Resources Inc (PINKSHEETS: BRYN) (PINKSHEETS: BRYN.PK). The company has received a number of investor calls for the past two weeks. Many of the calls reference the share price of the company. The recent surge in volume and the buying interest in the company's stock could be due to some of the recent meetings and calls held with institutional investors in the US and Canada. Bryn Resource Inc. was well received by those investors because of the company's new focus on acquiring producing and near producing properties. The company anticipates being able to deliver some more strong acquisition news in the next seven to ten business days. The company stated mission is to acquire North American gold producing properties. We believe we have identified a handful of new targets which would fit well into our timeline of 0 to 12 months development. Furthermore, Bryn Resources Inc will be in a position to announce some notable additions to the management and board of directors' team. The new acquisition program has caught the attention of some industry heavyweights and we expect to be able to finalize appointments before month end. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from to time in the Company's periodic reports filed with the Securities and Exchange Commission. Xcellink International Adds Top Technology Executive to Board of Advisors to Devise "To Market Strategy" for Chinese Mobile Banking LAS VEGAS, NV, Nov 17, 2009 -- Xcellink International Inc. (OTCBB: XCEL), a developer of patented mobile payments & banking platforms, is pleased to announce that it has appointed Mr. Dan Clayton to its Advisory Board. Mr. Clayton is a successful Internet IT entrepreneur and investor excelling in continuous innovation in Internet applications and development. He is a graduate of Harvard University and has a degree in Computer Science. Mr. Clayton currently resides in Beijing where he heads a team of 50+ PhD and Master's level developers who have created and developed, under Mr. Clayton's direction, what is the leading video search technology in the world. This technology, protected by 9 patents and 18 pending patents, operates under the banner of Hong Kong based ClairNET LTD., and its Chinese subsidiary, Leexoo Corp, both of which Mr. Clayton is Managing Director and Chief Executive. Through strategic relationships and business joint ventures, ClairNET holds one of few exclusive Mobile Service Provider Licenses (MSP) with China Mobile, the World's largest mobile network of over 600 million subscribers enabling the distribution of content and applications over the China Mobile networks. A Company spokesperson commented, "We are thrilled to have Mr. Clayton join our Advisory Board, and we look forward to his insight and experience in the areas of financial security, market penetration and mobile banking dominance in the Chinese market place. Xcellink is continuing to recruit top executives to its team, and is building a strong rapport within the mobile technology industry." Mobile banking will take off over the next 5 years with Informa Telecoms & Media predicting that in 2013 almost 300 billion transactions worth more than $860 billion will be conducted using a mobile phone, which would represent a 12-fold increase in gross global transaction values in just five years. Informa predicts that by 2013, over 445 million mobile subscribers will be regularly using their mobile phone to purchase physical goods and services remotely. In 2008 about a third of the total of $71 billion in mobile payments and transactions was for mobile digital content, but Informa notes that by 2013 over 95 percent of mobile transactions will be for physical goods and services. About Xcellink Xcellink International Inc. is a developer of advanced platform-independent customer-centric payment systems and methodologies. Xcellink's patented system has the technical ability to replace all credit, debit, charge and smart cards, providing all functions of order, warehousing, delivery and payment for all types of goods and services in a customer-centric manner that is more efficient, economical, and secure than systems operating today. Xcellink's unique process enables customers, rather than the merchant, to initiate, control and pay for all transactions, without the need for credit cards, in real-time anywhere, anytime, and at a fraction of the cost of current transactions. Please visit www.xcellink.com Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of mentioned products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in reports filed with the Securities and Exchange Commission. About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies. www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button. Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market. Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx ((Comments on this story may be sent to [email protected])) (c) 2009 M2 COMMUNICATIONS |